Human Pegivirus infection and lymphoma risk and prognosis: a North American study
暂无分享,去创建一个
J. Cerhan | Y. Asmann | A. Feldman | T. Habermann | S. Slager | M. Liebow | S. Ansell | J. Stapleton | M. Maurer | M. Larson | A. Novak | G. Nowakowski | T. Call | B. Link | C. Allmer | J. Xiang | D. Klinzman | A. Famà | A. Fama | G. Nowakowski | M. Larson
[1] J. Cerhan,et al. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study. , 2017, International journal of epidemiology.
[2] S. Swerdlow. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .
[3] J. McLinden,et al. Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo , 2017, PLoS pathogens.
[4] E. Gould,et al. ICTV Virus Taxonomy Profile: Flaviviridae , 2017, The Journal of general virology.
[5] J. Cerhan,et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes , 2016, CA: a cancer journal for clinicians.
[6] R. L. Harrison,et al. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2016) , 2016, Archives of Virology.
[7] D. O’Connor,et al. Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection , 2015, Science Translational Medicine.
[8] Marion C Lanteri,et al. Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood Recipients. , 2015, The Journal of infectious diseases.
[9] H. Katki,et al. GBV-C infection and risk of NHL among U.S. adults. , 2014, Cancer research.
[10] Dennis P. Robinson,et al. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[11] M. Winters,et al. Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro. , 2014, The Journal of general virology.
[12] A. Pawełczyk,et al. Hepatitis C virus (HCV) infection of peripheral blood mononuclear cells in patients with type II cryoglobulinemia. , 2013, Human immunology.
[13] A. Pawełczyk,et al. Hepatitis G virus/GBV-C in serum, peripheral blood mononuclear cells and bone marrow in patients with hematological malignancies. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[14] A. Landay,et al. GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals , 2013, AIDS.
[15] A. Landay,et al. GB Virus C Particles Inhibit T Cell Activation via Envelope E2 Protein-Mediated Inhibition of TCR Signaling , 2013, The Journal of Immunology.
[16] J. Cerhan,et al. Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study. , 2012, Cytokine.
[17] K. Chaloner,et al. GB Virus C Infection Is Associated with Altered Lymphocyte Subset Distribution and Reduced T Cell Activation and Proliferation in HIV-Infected Individuals , 2012, PloS one.
[18] J. Stapleton,et al. Gb Virus C Infection is Associated with a Reduced Rate of Reactivation of Latent HIV and Protection against Activation-Induced T-Cell Death , 2012, Antiviral therapy.
[19] J. McLinden,et al. GB Virus C Envelope Protein E2 Inhibits TCR-Induced IL-2 Production and Alters IL-2–Signaling Pathways , 2012, The Journal of Immunology.
[20] G. Rutherford,et al. Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] Jack T. Stapleton,et al. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae , 2011, The Journal of general virology.
[22] B. Clotet,et al. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4+ T-cells , 2010, Antiviral therapy.
[23] R. Gascoyne,et al. GBV‐C/hepatitis G virus infection and non‐Hodgkin lymphoma: a case control study , 2010, International journal of cancer.
[24] N. J. Knowles,et al. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2015) , 2009, Archives of Virology.
[25] J. Stapleton,et al. GB virus type C interactions with HIV: the role of envelope glycoproteins , 2009, Journal of viral hepatitis.
[26] K. Chaloner,et al. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy , 2009, AIDS.
[27] H. Tillmann,et al. GBV‐C coinfection is negatively correlated to Fas expression and Fas‐mediated apoptosis in HIV‐1 infected patients , 2008, Journal of medical virology.
[28] D. van Baarle,et al. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients , 2008, Leukemia & lymphoma.
[29] A. Zignego,et al. Hepatitis C virus lymphotropism: lessons from a decade of studies. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[30] H. El‐Serag,et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. , 2007, JAMA.
[31] K. Chaloner,et al. Effect of Primer Selection on Estimates of GB Virus C (GBV-C) Prevalence and Response to Antiretroviral Therapy for Optimal Testing for GBV-C Viremia , 2006, Journal of Clinical Microbiology.
[32] K. Chaloner,et al. Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis , 2006, HIV medicine.
[33] J. Stapleton,et al. GB virus C replicates in primary T and B lymphocytes. , 2006, The Journal of infectious diseases.
[34] A. Witkowska. On the Role of sIL-2R Measurements in Rheumatoid Arthritis and Cancers , 2005, Mediators of inflammation.
[35] T. Economopoulos,et al. The Prevalence of Hepatitis C and Hepatitis G Virus Infection in Patients with B Cell Non-Hodgkin Lymphomas in Greece: A Hellenic Cooperative Oncology Group Study , 2004, Acta Haematologica.
[36] K. Matsuo,et al. Effect of hepatitis C virus infection on the risk of non‐Hodgkin's lymphoma: A meta‐analysis of epidemiological studies , 2004, Cancer science.
[37] J. Cerhan,et al. Hepatitis C virus infection and non‐hodgkin lymphoma: Results of the NCI‐seer multi‐center case‐control study , 2004, International journal of cancer.
[38] S. Wünschmann,et al. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MlP-lα, MIP-1β, and SDF-1 , 2004, The Lancet.
[39] J. Margolick,et al. Persistent GB virus C infection and survival in HIV-infected men. , 2004, The New England journal of medicine.
[40] J. Stapleton,et al. Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. , 2003, Virology.
[41] H. Doerr,et al. Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile , 2003, Annals of Internal Medicine.
[42] M. Gundogdu,et al. Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin's lymphoma. , 2002, Clinical and laboratory haematology.
[43] D. Hossfeld. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .
[44] S. Wünschmann,et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. , 2001, The New England journal of medicine.
[45] M. Manns,et al. Infection with GB virus C and reduced mortality among HIV-infected patients. , 2001, The New England journal of medicine.
[46] J. Stapleton,et al. Full-Length GB Virus C (Hepatitis G Virus) RNA Transcripts Are Infectious in Primary CD4-Positive T Cells , 2000, Journal of Virology.
[47] A E Yeo,et al. Effect of Hepatitis G Virus Infection on Progression of HIV Infection in Patients with Hemophilia , 2000, Annals of Internal Medicine.
[48] S. Robson,et al. Evidence that the GBV‐C/hepatitis G virus is primarily a lymphotropic virus , 2000, Journal of medical virology.
[49] B. Neuschwander‐Tetri,et al. Is hepatitis G/GB virus‐C virus hepatotropic? Detection of hepatitis G/GB virus‐C viral RNA in liver and serum , 1999, Journal of medical virology.
[50] F. Roudot-thoraval,et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. , 1999, The Journal of infectious diseases.
[51] T. Berg,et al. Dynamics of GB Virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication , 1999, Hepatology.
[52] W. Irving,et al. Hepatitis G virus infection in lymphoma and in blood donors. , 1998, Journal of clinical pathology.
[53] M. Manns,et al. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection , 1998, Hepatology.
[54] M. Manns,et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? , 1998, The Journal of infectious diseases.
[55] J. Rakela,et al. Detection of Hepatitis G Virus Replication Sites by Using Highly Strand-Specific Tth-Based Reverse Transcriptase PCR , 1998, Journal of Virology.
[56] D. Huhn,et al. Epidemiological and Clinical Aspects of Hepatitis G Virus Infection in Blood Donors and Immunocompromised Recipients of HGV‐Contaminated Blood , 1998, Vox sanguinis.
[57] J. Takamatsu,et al. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[58] S. Sauleda,et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long‐term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors , 1997, Hepatology.
[59] D. Vlahov,et al. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. , 1997, The Journal of infectious diseases.
[60] M. Chiaramonte,et al. Hepatitis G virus infection , 1997, The Lancet.
[61] H. Margolis,et al. Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.
[62] T. Pilot‐Matias,et al. Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.
[63] S. Jones. Non-Hodgkin lymphomas. , 1975, JAMA.
[64] M. J. Adams,et al. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013) , 2013, Archives of Virology.
[65] J. Cerhan,et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. , 2011, International journal of molecular epidemiology and genetics.
[66] R. Torella,et al. High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection. , 2002, Haematologica.
[67] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .